Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.
作者信息
Wilton D
出版信息
Postgrad Med J. 1975;51 Suppl 1:138-9.
PMID:1219673
Abstract
摘要
相似文献
1
Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.芬氟拉明新制剂用于肥胖糖尿病非洲人治疗的评估
Postgrad Med J. 1975;51 Suppl 1:138-9.
2
Fenfluramine in management of obese diabetics.
J Assoc Physicians India. 1980 Sep;28(9):287-95.
3
A clinical trial of a new fenfluramine preparation (Ponderax PA).一种新型芬氟拉明制剂（Ponderax PA）的临床试验。
Postgrad Med J. 1975;51 Suppl 1:159-60.
4
A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules.氟苯丙胺片（英国药典）与长效胶囊的疗效及可接受性比较。
Postgrad Med J. 1975;51 Suppl 1:160-2.
5
6
Phenformin compared with fenfluramine in the treatment of obese diabetic patients.苯乙双胍与芬氟拉明治疗肥胖糖尿病患者的比较。
Practitioner. 1976 May;216(1295):577-80.
7
Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.长效芬氟拉明用于治疗难治性肥胖的非糖尿病患者。
Postgrad Med J. 1975;51 Suppl 1:155-7.
8
[Hypoglycemic action of fenfluramine in obese diabetics].[芬氟拉明对肥胖糖尿病患者的降血糖作用]
Prensa Med Argent. 1971 Jul 16;58(20):1030-3.
9
[The treatment of the obese non-insulin-dependent patient with d-fenfluramine].[用右旋芬氟拉明治疗肥胖的非胰岛素依赖型患者]
Clin Ter. 1996 Apr;147(4):199-204.
10
Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.氟苯丙胺和苯丁胺对肥胖糖尿病移植患者成功进行食欲抑制治疗。
Transplant Proc. 1995 Feb;27(1):975-6.
引用本文的文献
1
Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.芬氟拉明：对其药理特性及在肥胖症治疗中的疗效综述。
Drugs. 1975;10(4):241-323. doi: 10.2165/00003495-197510040-00001.
Zotero 插件